Association Between Mean Platelet Volume and Benign Prostatic Hyperplasia: A Population Study from the TCLSIH Cohort Study

References

• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• De Nunzio C, Kramer G, Marberger M, et al. The controversial relationship between benign prostatic hyperplasia and prostate cancer: the role of inflammation. Eur Urol. 2011;60(1):106–117. doi:10.1016/j.eururo.2011.03.055
   PubMed Web of Science ®Google Scholar
• Zhang L, Wang Y, Qin Z, et al. Correlation between prostatitis, Benign prostatic hyperplasia and prostate cancer: a systematic review and meta-analysis. J Cancer. 2020;11(1):177–189. doi:10.7150/jca.37235
   PubMed Web of Science ®Google Scholar
• Devlin CM, Simms MS, Maitland NJ. Benign prostatic hyperplasia - what do we know? BJU Int. 2021;127(4):389–399. doi:10.1111/bju.15229
   PubMed Web of Science ®Google Scholar
• Post JM, Beebe-Dimmer JL, Morgenstern H, et al. The metabolic syndrome and biochemical recurrence following radical prostatectomy. Prostate Cancer. 2011;2011:245642. doi:10.1155/2011/245642
   PubMedGoogle Scholar
• Park YW, Kim SB, Kwon H, et al. The relationship between lower urinary tract symptoms/benign prostatic hyperplasia and the number of components of metabolic syndrome. Urology. 2013;82(3):674–679. doi:10.1016/j.urology.2013.03.047
   PubMed Web of Science ®Google Scholar
• Pan JG, Jiang C, Luo R, Zhou X. Association of metabolic syndrome and benign prostatic hyperplasia in Chinese patients of different age decades. Urol Int. 2014;93(1):10–16. doi:10.1159/000354026
   PubMed Web of Science ®Google Scholar
• Adorini L, Penna G, Fibbi B, Maggi M. Vitamin D receptor agonists target static, dynamic, and inflammatory components of benign prostatic hyperplasia. Ann N Y Acad Sci. 2010;1193(1):146–152. doi:10.1111/j.1749-6632.2009.05299.x
   PubMedGoogle Scholar
• Kramer G, Steiner GE, Handisurya A, et al. Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation. Prostate. 2002;52(1):43–58. doi:10.1002/pros.10084
   PubMed Web of Science ®Google Scholar
• Rifaioglu MM, Demirbas O, Gokce H, Davarci M. Mean platelet volume-a predictive factor for the diagnosis of nonsymptomatic prostatitis: results of univariate and multivariate models. Am J Mens Health. 2017;11(1):35–40. doi:10.1177/1557988315621144
   PubMed Web of Science ®Google Scholar
• Karaman H, Karakukcu C, Kocer D. Can mean platelet volume serve as a marker for prostatitis? Int J Med Sci. 2013;10(10):1387–1391. doi:10.7150/ijms.6126
   PubMed Web of Science ®Google Scholar
• Zhao S, Tang J, Shao S, Yan Y. The relationship between benign prostatic hyperplasia/lower urinary tract symptoms and mean platelet volume: the role of metabolic syndrome. Urol Int. 2016;96(4):449–458. doi:10.1159/000443313
   PubMed Web of Science ®Google Scholar
• Gasparyan AY, Ayvazyan L, Mikhailidis DP, Kitas GD. Mean platelet volume: a link between thrombosis and inflammation? Curr Pharm Des. 2011;17(1):47–58. doi:10.2174/138161211795049804
   PubMed Web of Science ®Google Scholar
• Yu B, He H, Zhang Q, et al. Soft drink consumption is associated with depressive symptoms among adults in China. J Affect Disord. 2015;172:422–427. doi:10.1016/j.jad.2014.10.026
   PubMed Web of Science ®Google Scholar
• Song K, Du H, Zhang Q, et al. Serum immunoglobulin M concentration is positively related to metabolic syndrome in an adult population: tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIH) Cohort Study. PLoS One. 2014;9(2):e88701. doi:10.1371/journal.pone.0088701
   PubMed Web of Science ®Google Scholar
• Zhu C, Wu J, Wu Y, et al. Triglyceride to high-density lipoprotein cholesterol ratio and total cholesterol to high-density lipoprotein cholesterol ratio and risk of benign prostatic hyperplasia in Chinese male subjects. Front Nutr. 2022;9:999995. doi:10.3389/fnut.2022.999995
   PubMed Web of Science ®Google Scholar
• Blanc M, Sacrini A, Avogadro A, et al. Prostatic volume: suprapubic versus transrectal ultrasonography in the control of benign prostatic hyperplasia. Radiol Med. 1998;95(3):182–187.
   PubMedGoogle Scholar
• Huh JS, Kim YJ, Kim SD. Prevalence of Benign prostatic hyperplasia on Jeju Island: analysis from a cross-sectional community-based survey. World J Mens Health. 2012;30(2):131–137. doi:10.5534/wjmh.2012.30.2.131
   PubMedGoogle Scholar
• Zhao SC, Xia M, Tang JC, Yan Y. Associations between metabolic syndrome and clinical benign prostatic hyperplasia in a northern urban Han Chinese population: a prospective cohort study. Sci Rep. 2016;6(1):33933. doi:10.1038/srep33933
   PubMedGoogle Scholar
• Lance MD, van Oerle R, Henskens YM, Marcus MA. Do we need time adjusted mean platelet volume measurements? Lab Hematol. 2010;16(3):28–31. doi:10.1532/LH96.10011
   PubMedGoogle Scholar
• Su Q, Yu B, He H, et al. Nut consumption is associated with depressive symptoms among chinese adults. Depress Anxiety. 2016;33(11):1065–1072. doi:10.1002/da.22516
   PubMed Web of Science ®Google Scholar
• Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15(7):539–553. doi:10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S
   PubMed Web of Science ®Google Scholar
• Expert Panel on Detection E, Treatment of High Blood Cholesterol in A. Executive summary of the third report of The National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285(19):2486–2497. doi:10.1001/jama.285.19.2486
   PubMed Web of Science ®Google Scholar
• Kobalava ZD, Kotovskaya YV, Babaeva LA, Moiseev VS. Validation of TM-2655 oscillometric device for blood pressure measurement. Blood Press Monit. 2006;11(2):87–90. doi:10.1097/01.mbp.0000200484.49540.12
   PubMed Web of Science ®Google Scholar
• Mancia G, De Backer G, Dominiczak A, et al. 2007 guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25(6):1105–1187. doi:10.1097/HJH.0b013e3281fc975a
   PubMed Web of Science ®Google Scholar
• Chobanian AV, Bakris GL, Black HR, et al. The seventh report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure: the JNC 7 report. JAMA. 2003;289(19):2560–2572. doi:10.1001/jama.289.19.2560
   PubMed Web of Science ®Google Scholar
• Craig CL, Marshall AL, Sjostrom M, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc. 2003;35(8):1381–1395. doi:10.1249/01.MSS.0000078924.61453.FB
   PubMed Web of Science ®Google Scholar
• Yang Y, Wang GY, Pan X. China Food Composition. Beijing: Peking University Medical Press; 2002.
   Google Scholar
• Alberti KG, Eckel RH, Grundy SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120(16):1640–1645. doi:10.1161/CIRCULATIONAHA.109.192644
   PubMed Web of Science ®Google Scholar
• Balbaloglu O, Korkmaz M, Yolcu S, Karaaslan F, Beceren NG. Evaluation of mean platelet volume (MPV) levels in patients with synovitis associated with knee osteoarthritis. Platelets. 2014;25(2):81–85. doi:10.3109/09537104.2013.776162
   PubMed Web of Science ®Google Scholar
• Velez-Paez JL, Tercero-Martinez W, Jimenez-Alulima G, et al. Neutrophil-to-lymphocyte ratio and mean platelet volume in the diagnosis of bacterial infections in COVID-19 patients. A preliminary analysis from Ecuador. Infez Med. 2021;29(4):530–537. doi:10.53854/liim-2904-5
   PubMedGoogle Scholar
• Cai N, Chen ZQ, Tao M, Fan WT, Liao W. Mean platelet volume and red blood cell distribution width is associated with prognosis in premature neonates with sepsis. Open Med. 2021;16(1):1175–1181. doi:10.1515/med-2021-0323
   Web of Science ®Google Scholar
• Chen L, Zhang Q. Predictive value of mean platelet volume for aneurysm recurrence in patients with aneurysmal subarachnoid hemorrhage after endovascular treatment. World Neurosurg. 2021;145:e32–e37. doi:10.1016/j.wneu.2020.09.003
   PubMed Web of Science ®Google Scholar
• Kramer G, Mitteregger D, Marberger M. Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur Urol. 2007;51(5):1202–1216. doi:10.1016/j.eururo.2006.12.011
   PubMed Web of Science ®Google Scholar
• Krieger JN, Nyberg L, Nickel JC. NIH consensus definition and classification of prostatitis. JAMA. 1999;282(3):236–237. doi:10.1001/jama.282.3.236
   PubMed Web of Science ®Google Scholar
• Bostanci Y, Kazzazi A, Momtahen S, Laze J, Djavan B. Correlation between benign prostatic hyperplasia and inflammation. Curr Opin Urol. 2013;23(1):5–10. doi:10.1097/MOU.0b013e32835abd4a
   PubMed Web of Science ®Google Scholar
• Bostwick DG, de la Roza G, Dundore P, Corica FA, Iczkowski KA. Intraepithelial and stromal lymphocytes in the normal human prostate. Prostate. 2003;55(3):187–193. doi:10.1002/pros.10224
   PubMed Web of Science ®Google Scholar
• Li J, Li Y, Cao D, et al. The association between histological prostatitis and benign prostatic hyperplasia: a single-center retrospective study. Aging Male. 2022;25(1):88–93. doi:10.1080/13685538.2022.2050360
   PubMedGoogle Scholar
• Gustafson B, Hammarstedt A, Andersson CX, Smith U. Inflamed adipose tissue: a culprit underlying the metabolic syndrome and atherosclerosis. Arterioscler Thromb Vasc Biol. 2007;27(11):2276–2283. doi:10.1161/ATVBAHA.107.147835
   PubMed Web of Science ®Google Scholar
• Lepor H. Pathophysiology, epidemiology, and natural history of benign prostatic hyperplasia. Rev Urol. 2004;6(Suppl 9):S3–S10.
   Google Scholar
• Gacci M, Vignozzi L, Sebastianelli A, et al. Metabolic syndrome and lower urinary tract symptoms: the role of inflammation. Prostate Cancer Prostatic Dis. 2013;16(1):101–106. doi:10.1038/pcan.2012.44
   PubMed Web of Science ®Google Scholar
• Tavil Y, Sen N, Yazici HU, Hizal F, Abaci A, Cengel A. Mean platelet volume in patients with metabolic syndrome and its relationship with coronary artery disease. Thromb Res. 2007;120(2):245–250. doi:10.1016/j.thromres.2006.10.005
   PubMed Web of Science ®Google Scholar